Janux Therapeutics, Inc. (JANX) vs LB Pharmaceuticals Inc Common Stock (LBRX)

A side-by-side comparison of Janux Therapeutics, Inc. and LB Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — JANX vs LBRX

growth of $100 · dividends reinvested · last 1y
JANX -32.0% (-32.0%/yr)LBRX +100.1% (+100.1%/yr)LBRX compounded faster over this window
50100150200250300Start $1002026$68$200
JANX LBRX

JANX vs LBRX: by the numbers

  • •JANX is the larger company ($1.05B vs $1.00B market cap).
  • •Both run net losses; LBRX's is the smaller (0.00% vs -321.81% net margin).

Metrics side by side

Valuation

MetricJANXLBRX
P/S ratio32.90N/A
P/B ratio1.133.01

Profitability

MetricJANXLBRX
Gross margin79.71%0.00%
Operating margin-1576.67%0.00%
Net margin-321.81%0.00%
ROE-11.06%-25.78%
ROIC-15.15%-28.14%

Growth (annualized)

MetricJANXLBRX
Revenue CAGR (5Y)105.89%N/A
Total return CAGR (5Y)-6.45%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.